Wockhardt today said its new drug discovery programme in anti-infective research has received a major boost after two of its drugs, WCK 771 and WCK 2349, received the Qualified Infectious Disease Product (QIDP)status from the US FDA.
Drug firm Wockhardt Wednesday said it has received the final approval from the US Food and Drug Administration (FDA) for marketing Nicardipine HCI injections
in 25mg/10 ml strength, used in the treatment of hypertension.
Pharmaceutical and biotechnology major Wockhardt Limited on Tuesday announced a 2.2 percent growth in consolidated sales revenues to stand at Rs 923 crore for the third quarter ended September 30, 2009.
In India`s biggest buyout deal in the
healthcare sector, second largest hospital chain Fortis
Healthcare today said it is acquiring 10 Wockhardt Hospitals
for Rs 909 crore, a move that would narrow down its gap with
market leader Apollo Hospitals.